Cutivate
Formulated to manage inflammatory skin conditions and designed to alleviate itching and redness.
Strengths: 10 · 20g
Where to Check Availability
Medicine details
- Conditions
- Alternative names
Flixovate
- Therapeutic class
Corticosteroid
- Pharmacological class
Corticosteroid
- Contraindications
rosacea; acne vulgaris; perioral dermatitis; bacterial or viral skin infections
- Minor side effects
burning sensation; itching; erythema
- Moderate side effects
skin atrophy; telangiectasia; hypopigmentation
- Dosage forms
Cream; Ointment
- Administration route
Cutaneous use
- Prescription status
POM
- Manufacturer
GlaxoSmithKline
- Onset Time
1–2 days
- Duration
not applicable
- Storage instructions
Store below 25°C.
- Age restrictions
Use with caution in children.
Precautions and warnings
avoid contact with eyes; do not use under occlusive dressings unless advised; use for shortest duration possible
Serious side effects
systemic adrenal suppression — requires immediate medical attention; secondary infection — requires immediate medical attention
Patient summary
Formulated to manage inflammatory skin conditions and designed to alleviate itching and redness.
Mechanism of action
Cutivate contains a potent corticosteroid that reduces inflammation by suppressing the body's immune response in the skin and reducing the production of chemical mediators responsible for redness and swelling.
Pregnancy and breastfeeding
Pregnancy: Use with caution and only for brief periods. Breastfeeding: Expected to be present in breast milk; use with caution.
Cutivate
Formulated to manage inflammatory skin conditions and designed to alleviate itching and redness.
Editorial Notes
- Active ingredient(s): Fluticasone Propionate
- Listed indication(s): Atopic Dermatitis, Psoriasis, Eczema
Usually available as
- 4 tubes - 10 g1450-10-g-17748
- 2 tubes - 20 g1450-20-g-17586